title: Toll-like receptors are key players in neurodegeneration.
abstract: The activation of innate immune response is initiated by engagement of pattern-recognition receptors (PPRs), such as Toll-like receptors (TLRs). These receptors are expressed in peripheral leukocytes and in many cell types in the central nervous system (CNS). The expression of TLRs in CNS was mainly studied in astrocytes and microglial cells. However, new evidence indicates that these receptors may play an important role in neuronal homeostasis. The expression of TLRs in the CNS is variable and can be modulated by multiple factors, including pro-inflammatory molecules, which are elevated in neurodegenerative diseases and can increase the expression of TLRs in CNS cells. Moreover, activation of TLRs induces the release of pro-inflammatory cytokines. Therefore, TLRs have been shown to play a role in several aspects of neurodegenerative diseases. Here we will discuss results reported in the recent literature concerning the participation of TLRs in neurodegenerative diseases.
authors: Centro de Investigaciones en Bioquimica Clinica e Inmunologia-CONICET, Departamento de Bioquimica Clinica, Facultad de Ciencias Quimicas, Universidad Nacional de Cordoba, Cordoba, Argentina.
authors: Daniela S
authors: DS
authors: Arroyo
authors: Javier A
authors: JA
authors: Soria
authors: Emilia A
authors: EA
authors: Gaviglio
authors: Maria C
authors: MC
authors: Rodriguez-Galan
authors: Pablo
authors: P
authors: Iribarren
references: J Neuroinflammation. 2008 Dec 12;5:53
references: 19077284
references: Curr Opin Immunol. 2006 Feb;18(1):3-9
references: 16343886
references: Eur J Immunol. 2010 Jun;40(6):1738-47
references: 20306472
references: Nat Rev Neurosci. 2007 Jan;8(1):57-69
references: 17180163
references: J Immunol. 2004 Sep 15;173(6):3916-24
references: 15356140
references: Proc Natl Acad Sci U S A. 2007 Aug 21;104(34):13798-803
references: 17693552
references: J Virol. 2005 Oct;79(20):12893-904
references: 16188991
references: Trends Immunol. 2011 Mar;32(3):104-9
references: 21269878
references: Brain. 2006 Nov;129(Pt 11):3006-19
references: 16984903
references: Am J Pathol. 2009 Dec;175(6):2430-8
references: 19850890
references: Neurobiol Dis. 2010 Mar;37(3):503-9
references: 19833208
references: J Biol Chem. 2007 May 18;282(20):14975-83
references: 17355971
references: J Neuropathol Exp Neurol. 2002 Nov;61(11):1013-21
references: 12430718
references: Eur J Immunol. 2008 Feb;38(2):565-75
references: 18203139
references: J Neuroinflammation. 2007 Oct 15;4:26
references: 17937799
references: Infect Immun. 2006 Aug;74(8):4841-8
references: 16861672
references: Cell. 2010 Mar 19;140(6):918-34
references: 20303880
references: Brain. 2005 Aug;128(Pt 8):1778-89
references: 15857927
references: J Neuroimmune Pharmacol. 2009 Dec;4(4):380-8
references: 19669893
references: Br J Pharmacol. 2006 Jan;147 Suppl 1:S232-40
references: 16402109
references: J Neurosci. 2008 Dec 17;28(51):13978-84
references: 19091986
references: Traffic. 2009 Jun;10(6):621-8
references: 19302269
references: J Neuroinflammation. 2010 Aug 17;7:46
references: 20712904
references: J Neurovirol. 2006 Jun;12(3):229-34
references: 16877304
references: Glia. 2002 Nov;40(2):133-9
references: 12379901
references: Glia. 2002 Nov;40(2):140-55
references: 12379902
references: J Virol. 2007 Sep;81(18):9838-50
references: 17626075
references: FASEB J. 2005 Dec;19(14):2032-4
references: 16219804
references: Brain. 2007 Nov;130(Pt 11):2816-29
references: 17890734
references: Nat Rev Neurosci. 2008 Jun;9(6):481-93
references: 18490917
references: Alzheimer Dis Assoc Disord. 2003 Jul-Sep;17 Suppl 3:S75-9
references: 14512820
references: J Immunol. 2005 Nov 1;175(9):6100-6
references: 16237106
references: Nat Rev Immunol. 2009 Aug;9(8):535-42
references: 19556980
references: Nat Immunol. 2010 May;11(5):373-84
references: 20404851
references: J Neurosci. 2009 Feb 11;29(6):1846-54
references: 19211891
references: Mol Neurodegener. 2011 Jan 14;6(1):5
references: 21235801
references: J Clin Invest. 2006 Feb;116(2):456-64
references: 16440059
references: J Neuropathol Exp Neurol. 1997 Apr;56(4):321-39
references: 9100663
references: Nat Immunol. 2009 Sep;10(9):958-64
references: 19684606
references: J Leukoc Biol. 1999 Apr;65(4):416-27
references: 10204569
references: J Neuroimmunol. 2010 Aug 25;225(1-2):5-12
references: 20537409
references: Nat Rev Immunol. 2009 Jun;9(6):429-39
references: 19461673
references: J Biol Chem. 2006 Feb 10;281(6):3651-9
references: 16339765
references: Nat Immunol. 2008 Apr;9(4):361-8
references: 18297073
references: Immunol Res. 2005;31(3):165-76
references: 15888909
references: Mediators Inflamm. 2010;2010:
references: 20706642
references: Arch Immunol Ther Exp (Warsz). 2002;50(3):187-96
references: 12098934
references: J Neurosci. 2009 Sep 23;29(38):11982-92
references: 19776284
references: Biochem Biophys Res Commun. 2005 Oct 28;336(3):925-33
references: 16157304
references: Neurobiol Dis. 2007 Jul;27(1):90-8
references: 17544285
references: Mol Neurodegener. 2009 Nov 16;4:47
references: 19917131
references: J Neurosci. 2007 Nov 21;27(47):13033-41
references: 18032677
references: J Neuroimmunol. 2010 Apr 15;221(1-2):7-14
references: 19931190
references: J Neurosci. 2005 Feb 16;25(7):1788-96
references: 15716415
references: Cell. 2006 Feb 24;124(4):783-801
references: 16497588
references: Trends Immunol. 2003 Jun;24(6):286-90
references: 12810098
references: Physiol Rev. 2001 Apr;81(2):741-66
references: 11274343
references: Nature. 2002 Nov 21;420(6913):324-9
references: 12447441
references: Brain. 2005 Nov;128(Pt 11):2705-12
references: 16230320
references: Nature. 2002 Nov 21;420(6913):329-33
references: 12447442
references: Brain Res Rev. 2009 Mar;59(2):278-92
references: 18822314
references: J Neurochem. 2006 Oct;99(1):1-12
references: 16899072
references: Arch Neurol. 2004 Oct;61(10):1613-5
references: 15477521
references: J Neurosci. 2003 Apr 1;23(7):2665-74
references: 12684452
references: Trends Immunol. 2007 Jan;28(1):12-8
references: 17129764
references: Brain Pathol. 2002 Jul;12(3):308-19
references: 12146799
references: Biochem Pharmacol. 2011 Apr 1;81(7):825-37
references: 21241665
references: J Neuroimmunol. 2005 Feb;159(1-2):12-9
references: 15652398
references: Proc Natl Acad Sci U S A. 1996 Nov 12;93(23):13170-5
references: 8917563
references: Nature. 2007 Oct 18;449(7164):819-26
references: 17943118
references: J Immunol. 2006 Dec 1;177(11):7505-9
references: 17114417
references: J Neuroimmunol. 2006 Dec;181(1-2):46-56
references: 17011049
references: Cell Cycle. 2007 Dec 1;6(23):2859-68
references: 18000403
references: J Neurosci. 2008 May 28;28(22):5784-93
references: 18509040
references: J Neurosci Methods. 2006 Jan 15;150(1):128-37
references: 16105687
references: J Neuroimmunol. 2002 Jun;127(1-2):59-68
references: 12044976
references: J Immunol. 2002 Jan 1;168(1):434-42
references: 11751990
references: J Neurosci. 2001 Jan 15;21(2):RC123
references: 11160457
references: Glia. 2003 Sep;43(3):281-91
references: 12898707
references: Brain Behav Immun. 2008 Feb;22(2):140-7
references: 17920811
references: Int Immunopharmacol. 2007 Oct;7(10):1271-85
references: 17673142
references: J Biol Chem. 2001 Jun 29;276(26):23645-52
references: 11316806
references: J Neuroimmunol. 2005 Dec;169(1-2):116-25
references: 16146656
references: J Biol Chem. 2009 Sep 11;284(37):25404-11
references: 19592493